• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-500
Device Problem Calibration Problem (2890)
Patient Problem Hypoglycemia (1912)
Event Date 05/06/2021
Event Type  Injury  
Manufacturer Narrative
Upon analysis of the system on the 6th of may 2021, it was observed that the system had first asserted low glucose alert at 7:36 pm est, which is approximately 1 hour before the customer support call was made.During the call the user mentioned the system was in sensor suspend phase and did not allow the user to enter calibration for 6 hours, which is per design.The user expressed hypoglycemic symptoms while on the call and at this time the system was already in sensor suspend phase and there were no sensor glucose readings displayed on the app.The system had started to alert the user of the hypo event around 7:36 pm est on (b)(6) 2021, approximately an hour before the user called to report the sensor suspend alert.Per dms alert history page, the low glucose alerts were asserted and displayed on the app until 8:11 pm est just before the sensor suspend alert at 8:16 pm est, at which point, the system stopped displaying glucose related alerts as glucose was blinded.This is per design.There is no further investigation needed at this time as the system did alert the user of the hypo event.
 
Event Description
On may 06th 2021, senseonics was made aware of an adverse event where user expressed hypoglycemic symptoms while on the call and at this time the system was already in sensor suspend phase and there were no sensor glucose readings displayed on the app.User did not provide date and time of the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20875-7005
MDR Report Key11943511
MDR Text Key254487297
Report Number3009862700-2021-00078
Device Sequence Number1
Product Code QCD
UDI-Device Identifier00817491021441
UDI-Public817491021441
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 05/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date01/14/2021
Device Model Number102208-500
Device Catalogue NumberFG-3300-01-001
Device Lot Number117558
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/06/2021
Initial Date FDA Received06/04/2021
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/14/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age83 YR
-
-